Skip to content
← Back to this collection

PUBLICATIONS · 24895230

HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Int J Cancer
Publication date
2015 Feb 1
First author
Zivanovic O

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Zivanovic O
      type
      Author
    2. name
      Abramian A
      type
      Author
    3. name
      Kullmann M
      type
      Author
    4. name
      Fuhrmann C
      type
      Author
    5. name
      Coch C
      type
      Author
    6. name
      Hoeller T
      type
      Author
    7. name
      Ruehs H
      type
      Author
    8. name
      Keyver-Paik MD
      type
      Author
    9. name
      Rudlowski C
      type
      Author
    10. name
      Weber S
      type
      Author
    11. name
      Kiefer N
      type
      Author
    12. name
      Poelcher ML
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Zivanovic O
      type
      Author
    2. name
      Abramian A
      type
      Author
    3. name
      Kullmann M
      type
      Author
    4. name
      Fuhrmann C
      type
      Author
    5. name
      Coch C
      type
      Author
    6. name
      Hoeller T
      type
      Author
    7. name
      Ruehs H
      type
      Author
    8. name
      Keyver-Paik MD
      type
      Author
    9. name
      Rudlowski C
      type
      Author
    10. name
      Weber S
      type
      Author
    11. name
      Kiefer N
      type
      Author
    12. name
      Poelcher ML
      type
      Author
    bibliography ids
    1. nci-bib-85f9ea87a32ed5fcf4cf1248
    book metadata
    content sha256
    a61049aec722f329f67a39ba0d0ae632e26fa688e588096398d9e07608c63f6e
    document type
    citation
    dois
    1. 10.1002/ijc.29011
    electronic publication date
    display
    2014 Jun 17
    precision
    day
    year
    2014
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:24895230
    immutable id
    pubmed:24895230@a61049aec722f329f67a39ba0d0ae632e26fa688e588096398d9e07608c63f6e
    journal
    abbreviation
    Int J Cancer
    issn electronic
    1097-0215
    issn print
    0020-7136
    issue
    3
    name
    International journal of cancer
    nlm unique id
    0042124
    pages
    699-708
    volume
    136
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      24895230
      provenance
      batch id
      063b6c38419f18d4021f
      provider
      NCBI PubMed ESummary
      record sha256
      3f323b1933f3dc2f90e489cd48bdcbd31603e0688bb4e502dacaccfdf4f9e80b
      response sha256
      5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
      retrieved at
      2026-09-09T23:47:02.607425+00:00
      publication date
      display
      2015 Feb 1
      precision
      day
      year
      2015
      publication types
      1. Clinical Trial, Phase I
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/24895230/
      title
      HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer.

      Preserved source evidence · Not medical advice